Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SYDE1 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-05 |
mRNA | SNIP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | MKNK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | DSC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | DHX16 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | PHF21A | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-05 |
mRNA | KCNN4 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | OVOL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | GJB5 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
mRNA | MT-CO2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |